PETACC 3. Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3). - Van Cutsem,E.; Labianca,R.; Hossfeld,D. (Proc ASCO, 2005)